Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced it has completed a successful...
Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced the successful completion of its...
Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced the appointment of industry...
Antheia, the pharmaceutical ingredient manufacturer transforming supply chains, today announced the appointment of John Nicols to Chair its Board of...
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt financing from...
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief...
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Zack McGahey as Chief...
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks, which is building the leading horizontal ...
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, announced today that it has raised $73M in Series B financing....
A new paper published today in the journal Nature describes the first successful microbial biosynthesis of the tropane alkaloids hyoscyamine and...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.